Search Results 691-700 of 18096 for monoclonal antibody

1. Myasthenia gravis - Diagnosis and treatment - Mayo Clinic

   Other medicines that are similar B-cell-depleting monoclonal antibodies may increase over time. These medicines are usually used when other treatments don't ...

2. Alzheimer's drug lecanemab granted full approval by FDA, Mayo Clinic expert weighs in

   A monoclonal antibody, lecanemab, shows promise in removing amyloid plaques from the brain, according to phase 3 trial results. Amyloid plaques are one of ...

3. Clinical trials - Oncology (Medical)

   Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

4. Doxorubicin Hydrochloride, Cyclophosphamide, And Paclitaxel With Or Without Bevacizumab In Treating Patients With Lymph Node-Positive Or High-Risk, Lymph Node-Negative Breast Cancer - Mayo Clinic

   Monoclonal antibodies, such as bevacizumab, may interfere with the ability of tumor cells to grow and spread. Bevacizumab may also stop the growth of breast ...

5. COVID-19 antibody testing - Mayo Clinic

   Learn how COVID-19 antibody testing is done to find out if you've had a past infection with SARS-CoV-2, the virus that causes coronavirus disease 2019.

6. Signs Midwest COVID-19 surge may be leveling off as Mayo Clinic prepares for first round of vaccinations

   As are the outpatient therapies, such as the monoclonal antibody treatments, Mayo Clinic is offering to help keep patients out of the hospitals. "We still ...

7. Chemotherapy For Breast Cancer Clinical Trials - Mayo Clinic Research

   The purpose of this study is to evaluate T cell and antibody immunity ... Monoclonal antibodies such as trastuzumab can locate tumor cells and either ...

8. Clinical trials - Oncology (Medical)

   Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

9. Bispecific antibody therapy: T-cell engagement - Mayo Clinic

   Some bispecific antibody therapies link immune T cells directly to cancer cells. One arm of the bispecific attaches to a T cell. The other arm attaches to ...

10. Tumor Size is Defining Factor to Response from Promising Melanoma Drug - Mayo Clinic News Network

    The likely reason for this finding is that MK-3475 is a monoclonal antibody that stimulates the body's immune system response to the tumors, Dr. Joseph says ...